301 – 310 of 802
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Concordance between genotype and blood group phenotype in the INTERVAL cohort of 50,000 English blood donors
(
- Contribution to conference › Abstract
-
Mark
Assessing the effect of obesity-related traits on multiple myeloma using a Mendelian randomisation approach
(
- Contribution to journal › Letter
-
Mark
Pathogenesis and Therapeutic Mechanisms in Immune Thrombocytopenia (ITP)
(
- Contribution to journal › Scientific review
- 2016
-
Mark
Novel treatment of severe combined immunodeficiency utilizing ex-vivo T-cell depleted haploidentical hematopoietic stem cell transplantation and CD45RA+ depleted donor lymphocyte infusions.
(
- Contribution to journal › Article
-
Mark
Fetal and neonatal alloimmune thrombocytopenia.
(
- Contribution to journal › Scientific review
-
Mark
Adverse events in apheresis: An update of the WAA registry data.
(
- Contribution to journal › Scientific review
-
Mark
The hematopoietic tumor suppressor interferon regulatory factor 8 (IRF8) is upregulated by the antimetabolite cytarabine in leukemic cells involving the zinc finger protein ZNF224, acting as a cofactor of the Wilms' tumor gene 1 (WT1) protein.
(
- Contribution to journal › Article
-
Mark
Phagocyte Function Decreases after High-Dose Treatment with Melphalan and Autologous Stem Cell Transplantation in Patients with Multiple Myeloma.
(
- Contribution to journal › Article
-
Mark
Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma.
(
- Contribution to journal › Article
-
Mark
miR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells.
(
- Contribution to journal › Article